INFORMATION MARKED BY [***] HAS BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED PORTION HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. PRODUCT DEVELOPMENT AND COMMERCIALIZATION SUBLICENSE AGREEMENTCommercialization Sublicense Agreement • November 8th, 2007 • Hana Biosciences Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledNovember 8th, 2007 Company Industry JurisdictionThis Development and Commercialization Sublicense Agreement (this “Agreement”) is made and entered into this 31st day of July, 2007 (the “Effective Date”), by and among HANA Biosciences, Inc., a Delaware corporation (“HANA”), PAR Pharmaceutical, Inc., a Delaware corporation (“PAR”), and NovaDel Pharma, Inc., a Delaware corporation (“NovaDel”).